Non-invasive prediction of preeclampsia using the maternal plasma cell-free DNA profile and clinical risk factors

Abstract excerpt

Background: Preeclampsia (PE) is a pregnancy complication defined by new onset hypertension and proteinuria or other maternal organ damage after 20 weeks of gestation. Although non-invasive prenatal testing (NIPT) has been widely used to detect fetal chromosomal abnormalities during pregnancy, its performance in combination with maternal risk factors to screen for PE has not been extensively validated. Our aim...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Genomics and Diagnostics
• Share to Pregnancy and preeclampsia studies
• Share to Prenatal Screening and Diagnostics